Management of anaemia in prostate cancer.
Anaemia is a frequent complication of prostate cancer and of its treatments. In Europe prostate cancer accounts for the 10.8% of all malignant neoplasms. Iatrogenic hypogonadism and age-related physiologic changes along with nutritional deficits contribute to increase prevalence of prostate cancer related anaemia. The reason of the present review is to provide clinicians with all aspects of a frequent and multifactorial co-morbidity, whose effects are often underestimated. Erythropoiesis pathology and causes of anaemia in prostate cancer are reviewed. Critical issues of clinical management of anaemia in prostate cancer are discussed.
Division of Medical Oncology, ASL-1 Imperiese, Ospedale Civile, Sanremo, Italy.
Giuseppe
G
Colloca
Antonella
A
Venturino
Pasquale
P
Vitucci
Walter
W
Gianni
D000740:Anemia / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D004920:Erythropoiesis; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood / Q000150:complications* / Q000523:psychology; D011788:Quality of Life